Atlas Trials

Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer

Clinical trial NCT01327781 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01327781
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
HER2/Neu PositiveRecurrent Breast CarcinomaStage IIIC Breast Cancer AJCC v7Stage IV Breast Cancer AJCC v6 and v7
Start date
2011-03-25
Primary completion
2017-03-05
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.